Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Axogen, Inc. - Common Stock (NQ:AXGN)

41.37 +0.22 (+0.53%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 29, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,509,782
Open 38.31
Bid (Size) 38.25 (200)
Ask (Size) 46.80 (100)
Prev. Close 41.15
Today's Range 38.31 - 46.15
52wk Range 12.38 - 46.95
Shares Outstanding 41,397,053
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
AxoGen Q2 Earnings Call Highlights ↗
AxoGen (NASDAQ:AXGN) reported second-quarter 2026 revenue of $69.7 million, up 23.1% from a year earlier, as demand for its Avance nerve graft and broader product portfolio increased across its target... 
Via MarketBeat
Topics Earnings
Axogen (NASDAQ:AXGN) Shares Slide After Q2 Earnings Miss Overshadows Revenue Beat and Raised Guidance ↗
Via Chartmill
Topics Earnings

Performance

YTD
+33.5%
+33.5%
1 Month
-7.5%
-7.5%
3 Month
-1.5%
-1.5%
6 Month
+19.6%
+19.6%
1 Year
+218.5%
+218.5%

More News

Read More
News headline image
Axogen, Inc. Reports Second Quarter 2026 Financial Results
From Axogen, Inc.
Via GlobeNewswire
News headline image
Axogen, Inc. to Report Second Quarter 2026 Financial Results on July 29, 2026
From Axogen, Inc.
Via GlobeNewswire
Axogen Inc. (NASDAQ:AXGN) Achieves a Perfect Technical Score and Strong Fundamental Growth ↗
Via Chartmill
Axogen Inc (NASDAQ:AXGN) Rallies on Q1 Revenue Beat and Raised 2026 Guidance ↗
Via Chartmill
Axogen Inc (NASDAQ:AXGN) Reports Q4 2025 Revenue Growth but Misses Profit Estimates ↗
Via Chartmill
AXOGEN INC (NASDAQ:AXGN) Fits the Minervini Trend Template with Strong Growth Momentum ↗
Via Chartmill
News headline image
The Newest Name on Nasdaq Wants to Help the Body Rebuild Itself
From Energy Metal News
Via GlobeNewswire
News headline image
AxoGen Says Nerve Repair Strategy Intact as Reimbursement Wins Gather Steam ↗
Via MarketBeat
News headline image
TELA Bio Announces Strategic Board Refreshment with Four Highly Experienced Commerical Leaders to Accelerate Growth and Drive Path to Profitability; The Company Also Reports Preliminary First Quarter 2026 Revenues
From TELA Bio, Inc.
Via GlobeNewswire
News headline image
Axogen, Inc. to Participate in the 2026 Bank of America Global Healthcare Conference
From Axogen, Inc.
Via GlobeNewswire
News headline image
Axogen (AXGN) Q3 2025 Earnings Transcript ↗
Via The Motley Fool
News headline image
Axogen (AXGN) Q1 2025 Earnings Transcript ↗
Via The Motley Fool
News headline image
Axogen, Inc. Reports First Quarter 2026 Financial Results
From Axogen, Inc.
Via GlobeNewswire
News headline image
Capricorn Fund Makes a Huge Bet on Nerve Repair With 687,000 Share Axogen (AXGN) Investment Worth $22.4 Million ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Axogen (AXGN) Q2 2025 Earnings Transcript ↗
Via The Motley Fool
News headline image
Axogen, Inc. to Report First Quarter 2026 Financial Results on April 28, 2026
From Axogen, Inc.
Via GlobeNewswire
News headline image
Axogen Insider Sale of 5,221 Shares Follows 20% Revenue Growth in 2025. Here's What to Know ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
This $6.5 Million Healthcare Trim Comes Amid a 71% Stock Surge and 20% Revenue Growth ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Axogen (AXGN) Q4 2025 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings
News headline image
HighMark Wealth Management Buys 158,855 Shares of Axogen Stock ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Axogen, Inc. Reports Fourth Quarter and Full-Year 2025 Financial Results
From Axogen, Inc.
Via GlobeNewswire
News headline image
Axogen, Inc. to Participate in Multiple Upcoming Investor Conferences
From Axogen, Inc.
Via GlobeNewswire
News headline image
Axogen, Inc. to Report Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026
From Axogen, Inc.
Via GlobeNewswire

Frequently Asked Questions

Is Axogen, Inc. - Common Stock publicly traded?
Yes, Axogen, Inc. - Common Stock is publicly traded.
What exchange does Axogen, Inc. - Common Stock trade on?
Axogen, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Axogen, Inc. - Common Stock?
The ticker symbol for Axogen, Inc. - Common Stock is AXGN on the Nasdaq Stock Market
What is the current price of Axogen, Inc. - Common Stock?
The current price of Axogen, Inc. - Common Stock is 41.37
When was Axogen, Inc. - Common Stock last traded?
The last trade of Axogen, Inc. - Common Stock was at 07/29/26 04:00 PM ET
What is the market capitalization of Axogen, Inc. - Common Stock?
The market capitalization of Axogen, Inc. - Common Stock is 1.71B
How many shares of Axogen, Inc. - Common Stock are outstanding?
Axogen, Inc. - Common Stock has 2B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.